Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Linzess® (linaclotide) – New indication
June 12, 2023 - Ironwood Pharmaceuticals announced the FDA approval of Linzess (linaclotide), for the treatment of functional constipation (FC) in pediatric patients 6 to 17 years of age.
